日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

High-dose versus standard-dose intermittent meropenem in critically ill patients: An observational cohort study

危重患者间歇性使用高剂量与标准剂量美罗培南的比较:一项观察性队列研究

Bergmann, Felix; Prager, Marlene; Pracher, Lena; Kumpf, Katarina; Zeitlinger, Markus; Jorda, Anselm

Plasma and parasternal subcutaneous tissue pharmacokinetics of ceftaroline fosamil in cardiac surgery with cardiopulmonary bypass

在体外循环心脏手术中,头孢洛林磷酸酯的血浆和胸骨旁皮下组织药代动力学研究

Edlinger-Stanger, Maximilian; Bergmann, Felix; Jaeger, Walter; Boehmdorfer, Michaela; Zeitlinger, Markus; Hutschala-Kinstner, Doris

Randomized, Double-Blind, Phase I Pharmacokinetic Study of Subcutaneous Recombinant Human Superoxide Dismutase (rhSOD) in Healthy Volunteers

健康志愿者皮下注射重组人超氧化物歧化酶 (rhSOD) 的随机、双盲、I 期药代动力学研究

Al Jalali, Valentin; Bauer, Martin; Jorda, Anselm; Bergmann, Felix; Wölfl-Duchek, Michael; Partl, Richard; Vcelar, Brigitta; Katinger, Dietmar; Bashur, Rawad; Schnidar, Harald; Zeitlinger, Markus

Viral kinetics in adults with Covid-19 treated with nirmatrelvir-ritonavir or molnupiravir: a population-based, observational cohort study

接受尼马曲韦-利托那韦或莫努匹韦治疗的新冠肺炎成年患者的病毒动力学:一项基于人群的观察性队列研究

Prager, Marlene; Ensle, Dominik; Eser, Hubert; Glötzl, Florentin; Riedl, Benjamin; Szell, Marton; Valipour, Arschang; Zoufaly, Alexander; Wenisch, Christoph; Haider, Doris; Burgmann, Heinz; Thalhammer, Florian; Götzinger, Florian; Jilma, Bernd; Karnthaler, Ursula; Zeitlinger, Markus; Jorda, Anselm

The magnitude of the pharmacodynamic index for NOSO-502: pathogen clearance, emergence of resistance and human dose predictions

NOSO-502药效学指标的大小:病原体清除、耐药性的出现和人体剂量预测

van den Berg, Sanne; Attwood, Marie; Griffin, Pippa; Noel, Alan; Das, Shampa; Zeitlinger, Markus; Racine, Emilie; Boulenc, Xavier; Muller, Anouk E; Sassen, Sebastiaan D T; Bahmany, Soma; Ten Kate, Marian T; MacGowan, Alasdair; Meletiadis, Joseph

Experimental biofilm models for pharmacokinetic and pharmacodynamic investigations: bridging in vitro, ex vivo and in vivo systems

用于药代动力学和药效学研究的实验性生物膜模型:连接体外、离体和体内系统

Supparitsch, Stephanie; Zeitlinger, Markus

Malignant nodular fasciitis, a rare manifestation of a benign disease: case report

恶性结节性筋膜炎:一种良性疾病的罕见表现——病例报告

Aboulafia, Albert J; Liddy, Nicole; Zeitlinger, Lauren; Molavi, Diana W; Murali, Sudarsan; Aboulafia, David

Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units-the SAFE-ICU study

目前抗真菌药物的剂量是否足以满足危重患者的需求?一项国际多中心药代动力学研究——重症监护病房抗真菌药物暴露筛查(SAFE-ICU 研究)的结果

Roberts, Jason A; Sime, Fekade B; Lipman, Jeffrey; Hernández-Mitre, María Patricia; Baptista, João Pedro; Brüggemann, Roger J; Darvall, Jai; De Waele, Jan J; Dimopoulos, George; Lefrant, Jean-Yves; Mat Nor, Mohd Basri; Rello, Jordi; Seoane, Leonardo; Slavin, Monica A; Valkonen, Miia; Venditti, Mario; Ceccarelli, Giancarlo; Wong, Wai Tat; Zeitlinger, Markus; Roger, Claire

Interpreting regulatory mechanisms of Hippo signaling through a deep learning sequence model

通过深度学习序列模型解读Hippo信号通路调控机制

Khyati Dalal,Charles McAnany,Melanie Weilert,Mary Cathleen McKinney,Sabrina Krueger,Julia Zeitlinger

Evaluation of the need for dosing adaptations in obese patients for surgical antibiotic prophylaxis: a model-based analysis of cefazolin pharmacokinetics

评估肥胖患者手术抗生素预防用药剂量调整的必要性:基于模型的头孢唑林药代动力学分析

Bindellini, Davide; Simon, Philipp; Busse, David; Michelet, Robin; Petroff, David; Aulin, Linda B S; Dorn, Christoph; Zeitlinger, Markus; Huisinga, Wilhelm; Wrigge, Hermann; Kloft, Charlotte